Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 315, Issue 4, 2004, Pages 950-958

  Huang, Jhy Shrian ^a,d   Chao, Chuan Chuan ^d   Su, Teh Li ^d   Yeh, Shiou Hwei ^d   Chen, Ding Shinn ^b   Chen, Chiung Tong ^c   Chen, Pei Jer ^b   Jou, Yuh Shan ^a,d  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Div Biotech Pharmaceutical Res   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cellular transformation; Hepatocellular carcinoma; Overexpression; Tong HCC

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL TRANSFORMATION; CLIC1 GENE; COLONY FORMATION; CONTROLLED STUDY; DDX3 GENE; EIF3S2 GENE; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; GPC3 GENE; HDGF GENE; HSPCA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL;

EID: 84983723471     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.151     Document Type: Article

References (46)

1. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer. 37(Suppl. 8):2001;S4-S66.
2. Chen P.J., Chen D.S. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives. Semin. Liver Dis. 19:1999;253-262.
3. El-Serag H.B. Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 35:2002;S72-S78.
4. Bosch F.X., Ribes J., Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis. 19:1999;271-285.
5. Leong A.S.-Y. Epidemiology, risk factors, etiology, premalignant lesions and carcinogenesis. Leong A.S.-Y., Liew C.T., Lau J.W.Y., Johnson P.J. Hepatocellular Carcinoma: Diagnosis, Investigation and Management. 1999;1-17 Oxford University Press, New York.
6. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31:2002;339-346.
7. Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J., Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 21:2002;2593-2604.
8. Tannapfel A., Wittekind C. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch. 440:2002;345-352.
9. Peng S.Y., Lai P.L., Hsu H.C. Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. J. Formos. Med. Assoc. 92:1993;866-870.
10. Zhang Y.J., Jiang W., Chen C.J., Lee C.S., Kahn S.M., Santella R.M., Weinstein I.B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 196:1993;1010-1016.
11. Higashitsuji H., Itoh K., Nagao T., Dawson S., Nonoguchi K., Kido T., Mayer R.J., Arii S., Fujita J. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat. Med. 6:2000;96-99.
12. Ince N., de la Monte S.M., Wands J.R. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res. 60:2000;1261-1266.
13. Zeng J.Z., Wang H.Y., Chen Z.J., Ullrich A., Wu M.C. Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma. Oncogene. 21:2002;4932-4943.
14. Higashitsuji H., Nagao T., Nonoguchi K., Fujii S., Itoh K., Fujita J. A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis. Cancer Cell. 2:2002;335-346.
15. McGlynn K.A., Edmonson M.N., Michielli R.A., London W.T., Lin W.Y., Chen G.C., Shen F.M., Buetow K.H. A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas. Hepatology. 36:2002;1341-1348.
16. Luo J.H., Puc J.A., Slosberg E.D., Yao Y., Bruce J.N., Wright T.C. Jr., Becich M.J., Parsons R. Differential subtraction chain, a method for identifying differences in genomic DNA and mRNA. Nucleic Acids Res. 27:1999;e24.
17. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
18. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347:2002;1593-1603.
19. Drayton S., Peters G. Immortalisation and transformation revisited. Curr. Opin. Genet. Dev. 12:2002;98-104.
20. Combes R., Ball M., Curren R., Fischbach M., Fusenig M., Kirkland D., Lasne C., Landolph J., LeBoeuf R., Marquardt H., McCormick J., Muller L., Rivedal E., Sabbioni E., Tanaka N., Vasseur P., Yamasaki H. Cell transformation assays as predictors of human carcinogenicity. ATLA 27. 1999;745-767.
21. Asano K., Kinzy T.G., Merrick W.C., Hershey J.W. Conservation and diversity of eukaryotic translation initiation factor eIF3. J. Biol. Chem. 272:1997;1101-1109.
22. Mayeur G.L., Hershey J.W. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514:2002;49-54.
23. Nupponen N.N., Porkka K., Kakkola L., Tanner M., Persson K., Borg A., Isola J., Visakorpi T. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am. J. Pathol. 154:1999;1777-1783.
24. Pincheira R., Chen Q., Zhang J.T. Identification of a 170-kDa protein over-expressed in lung cancers. Br. J. Cancer. 84:2001;1520-1527.
25. Chen R.H., Miettinen P.J., Maruoka E.M., Choy L., Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature. 377:1995;548-552.
26. Yakicier M.C., Irmak M.B., Romano A., Kew M., Ozturk M. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene. 18:1999;4879-4883.
27. Kim Y.S., Lee S.G., Park S.H., Song K. Gene structure of the human DDX3 and chromosome mapping of its related sequences. Mol. Cells. 12:2001;209-214.
28. You L.R., Chen C.M., Yeh T.S., Tsai T.Y., Mai R.T., Lin C.H., Lee Y.H. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol. 73:1999;2841-2853.
29. Ashley R.H. Challenging accepted ion channel biology: p64 and the CLIC family of putative intracellular anion channel proteins (Review). Mol. Membr. Biol. 20:2003;1-11.
30. Valenzuela S.M., Mazzanti M., Tonini R., Qiu M.R., Warton K., Musgrove E.A., Campbell T.J., Breit S.N. The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J. Physiol. 529(Pt 3):2000;541-552.
31. Caplan A.J., Jackson S., Smith D. Hsp90 reaches new heights. Conference on the Hsp90 chaperone machine. EMBO Rep. 4:2003;126-130.
32. Blagosklonny M.V. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia. 16:2002;455-462.
33. Nakatsura T., Yoshitake Y., Senju S., Monji M., Komori H., Motomura Y., Hosaka S., Beppu T., Ishiko T., Kamohara H., Ashihara H., Katagiri T., Furukawa Y., Fujiyama S., Ogawa M., Nakamura Y., Nishimura Y. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem. Biophys. Res. Commun. 306:2003;16-25.
34. Midorikawa Y., Ishikawa S., Iwanari H., Imamura T., Sakamoto H., Miyazono K., Kodama T., Makuuchi M., Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer. 103:2003;455-465.
35. Zhu Z.W., Friess H., Wang L., Abou-Shady M., Zimmermann A., Lander A.D., Korc M., Kleeff J., Buchler M.W. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut. 48:2001;558-564.
36. Nakamura H., Izumoto Y., Kambe H., Kuroda T., Mori T., Kawamura K., Yamamoto H., Kishimoto T. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J. Biol. Chem. 269:1994;25143-25149.
37. Dietz F., Franken S., Yoshida K., Nakamura H., Kappler J., Gieselmann V. The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem. J. 366:2002;491-500.
38. Stevenson D., Lin J.H., Tong M.J., Marshall G.J. Characteristics of a cell line (Tong/HCC) established from a human hepatocellular carcinoma. Hepatology. 7:1987;1291-1295.
39. Nakanishi K., Sakamoto M., Yasuda J., Takamura M., Fujita N., Tsuruo T., Todo S., Hirohashi S. Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res. 62:2002;2971-2975.
40. Pang E., Wong N., Lai P.B., To K.F., Lau J.W., Johnson P.J. A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization. Cancer Genet. Cytogenet. 121:2000;9-16.
41. Niketeghad F., Decker H.J., Caselmann W.H., Lund P., Geissler F., Dienes H.P., Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br. J. Cancer. 85:2001;697-704.
42. Ng I.O., Guan X.Y., Poon R.T., Fan S.T., Lee J.M. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J. Pathol. 199:2003;345-353.
43. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 18:1997;59-65.
44. Lin Y.W., Sheu J.C., Huang G.T., Lee H.S., Chen C.H., Wang J.T., Lee P.H., Lu F.J. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. Eur. J. Cancer. 35:1999;652-658.
45. Chen Y.J., Yeh S.H., Chen J.T., Wu C.C., Hsu M.T., Tsai S.F., Chen P.J., Lin C.H. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology. 119:2000;431-440.
46. Wilkens L., Bredt M., Flemming P., Becker T., Klempnauer J., Kreipe H.H. Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J. Pathol. 193:2001;476-482.